Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 21814496.
- Also identified by DOI 10.1371/journal.pmed.1001063 and PMC identifier 3144197.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.
Medical subject headings
- Molecular Diagnostic Techniques
- Mycobacterium tuberculosis
- Polymerase Chain Reaction
- Tuberculosis, Pulmonary